M.V. Pilipecz et al. / Tetrahedron 64 (2008) 5545–5550
5549
m), 1.69 (2H, m), 2.61 (1H, t, J¼8.1 Hz), 2.61 (1H, t, J¼8.1 Hz), 2.90
(1H, t, J¼8.1 Hz), 2.90 (1H, t, J¼8.1 Hz), 3.10 (2H, m), 3.91 (2H, m); dC
(DMSO-d6) 22.2, 26.0, 28.0, 28.0, 28.1, 30.6, 42.1, 130.6, 152.9, 169.3;
HRMS (ESI-TOF) calcd for C10H15N2O3: 211.1083 ([MþH]þ), found:
211.1082 ([MþH]þ).
(DMSO-d6) 1.90 (3H, d, J¼6.2 Hz), 1.94 (2H, q, J¼6.8 Hz), 2.87 (2H,
dt, J1¼1.8 Hz, J2¼7.0 Hz), 3.85 (2H, t, J¼6.8 Hz), 5.27 (1H, s), 5.36 (1H,
q, J¼0.6 Hz), 6.18 (1H, t, J¼1.8 Hz); d (DMSO-d6) 19.6, 21.7, 33.1,
C
53.4, 76.1, 118.0, 119.4, 140.8, 171.7; HRMS (ESI-TOF) calcd for
C
10H13N2O: 177.1028 ([MþH]þ), found: 177.1026 ([MþH]þ).
4.2.3.11. 1-Nitro-6,7,8,9,10,10a-hexahydro-3H-pyrido[1,2-a]azepin-
4-one (10b). Purification of the product by column chromatogra-
phy (diethyl ether) gave the title compound 10b (233 mg, 37%) as
a colorless oil; Rf (EtOAc) 0.61; nmax (KBr) 2958, 2360, 1646, 1544,
1396, 1349, 1329, 1220, 1173 cmꢁ1; dH (DMSO-d6) 1.65 (1H, m), 1.65
(1H, m), 1.70 (2H, m), 2.30 (1H, m), 2.30 (1H, m), 2.35 (2H, m), 2.35
(2H, m), 3.02 (1H, dt, J1¼4.0 Hz, J2¼12.8 Hz), 4.30 (1H, dt, J1¼7.0 Hz,
J2¼12.8 Hz), 5.46 (1H, dd, J1¼6.0 Hz, J2¼6.4 Hz), 5.58 (1H, t,
4.2.3.17. [1-(3-Phenyl-acryloyl)-pyrrolidin-2-ylidene]-acetonitrile
(12f). Purification of the product by column chromatography
(dichloromethane) gave the title compound 12f (207 mg, 29%) as
a white solid, mp 164–165 ꢀC; Rf (dichloromethane) 0.33; nmax (KBr)
3108, 2360, 2197, 1670, 1617, 1396, 1340, 1245 cmꢁ1; dH (DMSO-d6)
1.97 (2H, q, J¼7.0 Hz), 2.87 (2H, dt, J1¼1.4 Hz, J2¼7.0 Hz), 4.10 (2H, t,
J¼7.0 Hz), 6.35 (1H, s), 7.08 (1H, d, J¼15 Hz), 7.43 (2H, m), 7.43 (1H,
m), 7.64 (1H, d, J¼15 Hz), 7.76 (2H, m); dC (DMSO-d6) 21.0, 32.9, 51.7,
75.7, 119.5, 119.7, 128.9, 129.2, 130.8, 134.7, 144.8, 161.4, 166.3; HRMS
(ESI-TOF) calcd for C15H15N2O: 239.1184 ([MþH]þ), found: 239.1186
([MþH]þ).
J¼3.2 Hz); d (DMSO-d6) 24.0, 24.1, 25.8, 26.9, 28.9, 28.1, 45.5, 84.2,
C
121.1, 135.4, 167.7; HRMS (ESI-TOF) calcd for C10H15N2O3: 211.1083
([MþH]þ), found: 211.1083 ([MþH]þ).
4.2.3.12. 5-Oxo-1,2,3,5,6,7-hexahydro-indolizine-8-carbonitrile
(12a). Purification of the product by column chromatography (tert-
butyl methyl ether) gave the title compound 12a (379 mg, 78%) as
a white solid, mp 50–52 ꢀC; Rf (EtOAc) 0.60; nmax (KBr) 2902, 2359,
4.2.3.18. 9,10-Dimethoxy-4-oxo-3,4,6,7-tetrahydro-2H-pyrido[2,1-
a]isoquinoline-1-carbonitrile (14a). Recrystallization from 2-
propanol gave 14a (89 mg, 73%) as a pale yellow solid, mp 151–
152 ꢀC; Rf (EtOAc) 0.57; n
(KBr) 2946, 2192, 1689, 1515, 1374,
max
2201, 1685, 1654, 1387, 1317, 1275 cmꢁ1; d (DMSO-d6) 1.93 (2H, q,
1282, 1131 cmꢁ1; dH 2.69 (4H, s), 2.81 (2H, t, J¼6.0 Hz), 3.85 (2H, t,
H
J¼7.0 Hz), 2.48 (2H, s), 2.48 (2H, s), 2.83 (2H, t, J¼7.0 Hz), 3.62 (2H, t,
J¼6.0 Hz), 3.93 (3H, s), 3.96 (3H, s), 6.70 (1H, s), 7.77 (1H, s); d
C
J¼7.0 Hz); d (DMSO-d6) 20.7, 20.9, 30.1, 30.6, 46.9, 78.2,119.6,156.7,
(CDCl3) 23.1, 28.4, 30.4, 39.2, 55.9, 56.2, 83.0, 110.1, 110.7, 119, 9,
120.8, 130.5, 147.6, 147.9, 151.0, 169.1; HRMS (ESI-TOF) calcd for
C
167.7; HRMS (ESI-TOF) calcd for C9H11N2O: 163.0871 ([MþH]þ),
found: 163.0867 ([MþH]þ).
C
16H17N2O3: 285.1239 ([MþH]þ), found: 285.1242 ([MþH]þ).
4.2.3.13. 7-Methyl-5-oxo-1,2,3,5,6,7-hexahydro-indolizine-8-carbo-
nitrile (12b). Purification of the product by column chromatogra-
phy (diethyl ether) gave the title compound 12b (106 mg, 20%) as
a white solid, mp 118–120 ꢀC; Rf (Et2O) 0.55; nmax (KBr) 2197, 1686,
1646, 1387, 1351, 1319, 1276, 1194 cmꢁ1; dH (DMSO-d6) 1.09 (3H, t,
J¼6.6 Hz), 1.94 (2H, q, J¼7.2 Hz), 2.48 (1H, dd, J1¼6.6 Hz, J2¼8.6 Hz),
2.65 (1H, dd, J1¼8.6 Hz, J2¼16.2 Hz), 2.73 (1H, m), 2.82 (2H, t,
4.2.3.19. 9,10-Dimethoxy-2-methyl-4-oxo-3,4,6,7-tetrahydro-2H-
pyrido[2,1-a]isoquinoline-1-carbonitrile (14b). Purification of the
product by column chromatography (isobutyl acetate) gave the title
compound 14b (73 mg, 57%) as a pale yellow solid, mp 176–177 ꢀC;
Rf (isobutyl acetate) 0.43; nmax (KBr) 2964, 2188, 1682, 1515, 1379,
1285, 1144 cmꢁ1; d (CDCl3) 1.20 (3H, d, J¼6.8 Hz), 2.36 (1H, dd,
H
J1¼7.6 Hz, J2¼7.4 Hz), 2.70 (1H, m), 2.74 (1H, m), 2.77 (2H, t,
J¼6.2 Hz), 3.71 (2H, t, J¼6.2 Hz), 3.80 (3H, s), 3.83 (3H, s), 6.82 (1H,
s), 7.62 (1H, s); dC (CDCl3) 18.5, 28.1, 38.0, 55.9, 89.0, 110.8, 111.2,
120.0, 120.3, 131.3, 147.1, 147.1, 151.0, 168.2; HRMS (ESI-TOF) calcd
for C17H19N2O3: 299.1396 ([MþH]þ), found: 299.1389 ([MþH]þ).
J¼7.2 Hz), 3.62 (2H, t, J¼7.2 Hz); d (DMSO-d6) 19.3, 21.0, 28.0, 30.6,
C
38.2, 46.9, 84.6, 118.9, 156.0, 167.4; HRMS (ESI-TOF) calcd for
C
10H13N2O: 177.1028 ([MþH]þ), found: 177.1025 ([MþH]þ).
4.2.3.14. (1-But-2-enoyl-pyrrolidin-2-ylidene)-acetonitrile (12c). Pu-
rification of the product by column chromatography (diethyl ether)
gave the title compound 12c (190 mg, 36%) as a white solid, mp
108–109 ꢀC; Rf (Et2O); 0.26; nmax (KBr) 2202, 1676, 1633, 1600, 1396,
4.2.3.20. 9,10-Dimethoxy-3-methyl-4-oxo-3,4,6,7-tetrahydro-2H-
pyrido[2,1-a]isoquinoline-1-carbonitrile (14c). Recrystallization
from 2-propanol gave 14c (74 mg, 58%) as a pale yellow solid, mp
168–169 ꢀC; Rf (50% methyl tert-butyl ether/chloroform) 0.60;
nmax (KBr) 2187, 1684, 1600, 1513, 1380, 1250, 1206, 1134 cmꢁ1; dH
(CDCl3) 1.50 (3H, d, J¼6.2 Hz), 2.53 (2H, dd, J1¼5.6 Hz,
J2¼16.0 Hz), 2.63 (1H, m), 2.79 (2H, m), 3.53 (1H, m), 3.78 (3H, s),
1340, 1312, 1246 cmꢁ1; d (DMSO-d6) 1.91 (2H, q, J¼7.6 Hz), 1.91
H
(3H, d, J¼3 Hz), 2.84 (2H, t, J¼7.6 Hz), 3.90 (2H, t, J¼7.6 Hz), 6.26 (1H,
s), 6.41 (1H, d, J¼14,0 Hz), 6.83 (1H, dq, J1¼3.0 Hz, J2¼14.0 Hz); d
C
(DMSO-d6) 18.3, 21.0, 32.9, 51.5, 75.4,119.7,123.8,145.4,161.3,166.1;
HRMS (ESI-TOF) calcd for C10H13N2O: 177.1028 ([MþH]þ), found:
177.1025 ([MþH]þ).
3.80 (1H, m), 3.81 (3H, s), 6.98 (1H, s), 7.66 (1H, s); d (CDCl3)
C
15.3, 28.0, 30.2, 34.0, 40.3, 56.0, 56.1, 82.0, 111.1, 111.3, 119.9, 121.4,
131.6, 147.2, 147.7, 151.1, 172.0; HRMS (ESI-TOF) calcd for
4.2.3.15. 6-Methyl-5-oxo-1,2,3,5,6,7-hexahydro-indolizine-8-carbo-
nitrile (12d). Purification of the product by column chromatogra-
phy (diisopropyl ether/dichloromethane 4:1) gave the title
compound 12d (127 mg, 24%) as a white solid, mp 103–104 ꢀC; Rf
(Et2O) 0.46; nmax (KBr) 2198, 1683, 1656, 1456, 1390, 1328,
1284 cmꢁ1; dH (DMSO-d6) 1.19 (3H,d, J¼6.2 Hz),1.94 (2H, q, J¼7 Hz),
2.25 (1H, m), 2.55 (1H, m), 2.55 (1H, m), 2.83 (2H, t, J¼7 Hz), 3.62
C
17H19N2O: 299.1396 ([MþH]þ), found: 299.1400 ([MþH]þ).
4.2.3.21. 9,10-Dimethoxy-4-oxo-2-phenyl-3,4,6,7-tetrahydro-2H-pyr-
ido[2,1-a]isoquinoline-1-carbonitrile (14d). Recrystallization from
2-propanol gave 14d (85 mg, 55%) as a yellow solid, mp 173–174 ꢀC;
Rf (EtOAc) 0.50; n
(KBr disc) 2189, 1641, 1596, 1555, 1462,
max
1273 cmꢁ1; dH (CDCl3) 2.89–3.06 (3H, m), 3.53 (2H, t, J¼6.2 Hz), 3.96
(2H, t, J¼7.0 Hz); d (DMSO-d6) 15.4, 21.1, 29.5, 30.6, 34.7, 47.1, 77.7,
(2H, m), 3.96 (3H, s), 4.00 (3H, s), 6.75 (1H, s), 7.38 (5H, m), 8.03 (1H,
C
119.5, 155.7, 170.8; HRMS (ESI-TOF) calcd for C10H13N2O: 177.1028
s); d (CDCl3) 27.83, 38.85, 56.02, 56.21, 78.90, 110.10, 110.39, 111.89,
C
([MþH]þ), found: 177.1026 ([MþH]þ).
118.51, 122.81, 124.05, 126.84, 128.26, 128.68, 129.05, 129.83, 131.88,
135.09, 141.32, 147.50, 152.56, 164.11, 187.63; HRMS (ESI-TOF) calcd
for C22H21N2O3: 361.1552 ([MþH]þ), found: 361.1560 ([MþH]þ).
4.2.3.16. [1-(2-Methyl-acryloyl)-pyrrolidin-2-ylidene]-acetonitrile
(12e). Purification of the product by column chromatography
(diisopropyl ether/dichloromethane 4:1) gave the title compound
12e (143 mg, 27%) as a white solid, mp 92–94 ꢀC; Rf (Et2O) 0.67;
nmax (KBr) 3108, 2202, 1668, 1610, 1383, 1343, 1232 cmꢁ1; dH
4.2.3.22. 2-(6,7-Dimethoxy-3,4-dihydro-2H-isoquinolin-1-ylidene)-
5-(4-methoxy-phenyl)-3-oxo-pent-4-enenitrile (15). The solution of
b-enaminonitrile 13 (1.0 g, 4.3 mmol) and 4-methoxycinnamoyl